SB-273005 is an orally active non-peptide alphavbeta3 integrin antagonist with Ki values of 1.2 nM and 0.3 nM for alphavbeta3 and alphavbeta5, respectively. SB-273005 blocks the binding of integrins to the RGD sequence in the extracellular matrix. SB-273005 inhibits Rictor phosphorylation and reduces IL-10 secretion. SB-273005 inhibits inflammation, prevents bone loss, regulates vascular smooth muscle function, and reverses pregnancy-induced immune deviation. SB-273005 can be used in the study of rheumatoid arthritis, osteoporosis, and aneurysms. [1][2][3][4][5].
Molekulargewicht:
451.44
Reinheit:
99.94
CAS Nummer:
[205678-31-5]
Formel:
C22H24F3N3O4
Target-Kategorie:
Integrin,Interleukin Related
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten